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Background: Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. (Hóng yá mù) (CF) has been used for
treatment of fever, cough, and peptic ulcer. Previously, a 50% ethanol-water extract from twigs of CF was shown
highly selective in cytotoxicity against cancer cells. This study aims to investigate the molecular mechanisms
underlying the apoptosis-inducing effect of CF.
Methods: The cytotoxicity of CF was evaluated in the human hepatocellular carcinoma (HCC) HepG2 cell line in
comparison with a non-cancerous African green monkey kidney epithelial cell line (Vero) by a neutral red assay. The
apoptosis induction mechanisms were investigated through nuclear morphological changes, DNA fragmentation,
mitochondrial membrane potential alterations, and caspase enzyme activities.
Results: CF selectively induced HepG2 cell death compared with non-cancerous Vero cells. A 1.5-fold higher
apoptotic effect compared with melphalan was induced by 120 μg/mL of the 50% ethanol-water extract of CF. The
apoptotic cell death in HepG2 cells occurred via extrinsic and intrinsic caspase-dependent pathways in dose- and
time-dependent manners by significantly increasing the activities of caspase 3/7, 8, and 9, decreasing the mitochondrial
membrane potential, and causing apoptotic body formation and DNA fragmentation.
Conclusions: CF extract induced a caspase-dependent apoptosis in HepG2 cells.Background
Hepatocellular carcinoma (HCC) is the fifth leading cancer
worldwide and the third cause of cancer death [1] with a
poor prognosis owing to the ineffectiveness of therapy [2].
The treatment options for HCC patients, such as surgical
resection and liver transplantation [2], are only appropriate
for the early stages of tumor development. A second pri-
mary site can be caused by a malignant clone even if the
first cancer site has been diagnosed and resected [1]. Che-
moprevention is considered to be another important* Correspondence: natthida@kku.ac.th
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of HCC by phytochemicals or non-nutritive plant com-
pounds. The development and research of new anticancer
agents has decreased HCC-associated mortality [2].
Some anti-cancer agents induced apoptosis of cancer
cells [3]. Apoptotic cancer cells are characterized by mor-
phological changes, including chromatin condensation,
membrane blebbing, and apoptotic body formation,
which are related to DNA fragmentation observed as a
ladder on gel electrophoresis [2]. Apoptosis comprises
two major pathways, the intrinsic and extrinsic pathways
[4]. The caspase enzymes are proteases playing an im-
portant role in the classification of apoptosis. Several
studies have screened potential compounds that can trig-
ger apoptosis via measurement of caspase activity [5-7].tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Cytotoxicity and selectivity index of 50% ethanol-water extract of CF on HepG2 cells compared with Vero cells
Sample Part
used
IC50 ± SD (μg/mL) Selectivity index (SI)
c
HepG2 Vero
Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. Twig 55.9 ± 10.6 Inactiveb 8.9
Melphalana 37.7 ± 9.8 59.9 ± 3.2 1.6
Data expressed as the mean ± SD of three determinations.
aStandard anticancer drug.
bIC50 > 500 μg/mL is considered inactive.
cSI referred to Selectivity Index, when SI value > 3 indicates high selectivity.
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adriamycin, and melphalan have been reported to eradi-
cate cancer via the induction of apoptosis [5,7-9].
Cratoxylum formosum (Jack) Dyer ssp. pruniflorum
(Kurz) Gogel. (CF) (Hóng yá mù or commonly known as
“Kuding Tea” in Southwest mainland China [10] and
“Tiew kon” in Thailand [11]) is widely found in South-
east Asia [12] and belongs to the family of Guttiferae.
Five other Cratoxylum species were found in Thailand
and Southwest China, namely Cratoxylum arborescens,
Cratoxylum cochinchinense, Cratoxylum maingayi, Cra-
toxylum sumatranum ssp. neriifolium, and Cratoxylum
formosum (Jack) Dyer [13].
CF has been used in Chinese medicine for treatment
of fever, cough, stomach ache, flatulence, diarrhea, food
poisoning, internal bleeding, and peptic ulcer [10,13]. It
has also been used as a diuretic and for its tonic effects
[10]. CF produces various secondary metabolites includ-
ing xanthones, anthraquinones [10,14], triterpenoids, fla-
vonoids [13-16], and phenolic compounds [6]. These
compounds are widely found in plants and some of
them have been shown to exert cytotoxic effects toward
some cancer cell lines and other biological activities such
as antibacterial effects and antimicrobial effects [10].
Fractions obtained from dichloromethane crude ex-
tract of CF roots was reported to exhibit anticancer ac-
tivity against MCF-7 human breast cancer cells, human
cervical cancer HeLa cells, colon cancer HT-29 cells,Figure 1 The HepG2 viability profile after treated with
melphalan or CF for 24 h (n = 3).and human oral cancer KB cells [13]. The cytotoxic ef-
fect of the CF extract was selectively high against human
leukemia cancer cells (U937) compared with normal
cells (Vero). Our group previously reported the apop-
totic effect of CF on U937 cells, based on observations
of DNA laddering and nuclear morphological changes
[8]. This study aims to investigate the molecular mecha-
nisms underlying the apoptosis-inducing effect.
Materials and methods
Reagents and chemicals
The organic solvents used for extraction were of analytical
grade and obtained from Fisher Scientific (Loughborough,
UK) and Labscan (Bangkok, Thailand). The reagents used
in the cell assays were of molecular biological grade. Dul-
becco’s modified Eagle’s medium (DMEM), fetal bovine
serum (FBS), penicillin, and streptomycin were purchased
from GIBCO® (Invitrogen Corporation, Carlsbad, CA,
USA). Standard reagents, melphalan, and 4′,6-diamidino-
2-phenylindole (DAPI) were obtained from Sigma-Aldrich
Inc. (St. Louis, MO, USA). Dimethylsulfoxide (DMSO)
was purchased from United States Biological (Salem, MA,
USA). The reagents for cytotoxicity testing included neu-
tral red (NR) and sodium bicarbonate (NaHCO3). We
used a FlexiGene DNA Kit (Qiagen GmbH, Germany),
isopropyl alcohol biotechnology grade (Bio Basic Inc.,
USA), and methanol analytical grade (BDH, England).
Agarose molecular grade was purchased from Bio-Rad
(Hercules, CA, USA). We purchased a 100 bp + 1.5 kb
DNA ladder stained with loading dye from SibEnzyme
Ltd. (Russia). Caspase-Glo® 3/7, 8, and 9 Assay Kits were
purchased from Promega (Madison, WI, USA). We ob-
tained 3,3′-dihexyloxacarbocyanine iodide (DiOC6) from
Sigma-Aldrich Inc. Pure concentrated hydrogen peroxide
(35%, v/v) was purchased from Qrec Co. Ltd. (New
Zealand).
Cell culture
An African green monkey kidney cell line (Vero) at pas-
sage 26 and a human HCC cell line (HepG2) at passage
40 were maintained in DMEM supplemented with 10%
FBS and 1% (w/v) penicillin/streptomycin. All cells were
cultured at 37°C in a humidified atmosphere containing
5% CO2.
(A)Melphalan treated HepG2  cells (B)C. formosum treated HepG2  cells (C)Control HepG2 cells (untreated)
(41.6±2.1%) (62.2±4.5%) (0%)
Figure 2 Nuclei morphological changes and percentage of apoptotic cells in HepG2 cells (A) after treatment with 80 μg/mL of
melphalan, (B) 120 μg/mL of CF, and (C) in the control or untreated HepG2 cells. Apoptotic bodies are indicated by white arrows. Pictures
captured using an inverted fluorescent microscope at 40 × objective magnification.
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Twigs of CF were collected in 2008 from the northeastern
region of Thailand. The plants were visually authenticated
according to taxonomy [17] and voucher specimens (TT-
OC-SK-862) were deposited at the Medicinal Herbarium
of the Faculty of Pharmaceutical Sciences, Khon Kaen Uni-
versity, Thailand. Briefly, 1 kg of dried plants was cut and
macerated with 6 L of 50% ethanol and water for 7 days.
The solvent was filtered, distilled in vacuo by a rotary
evaporator below 40°C, and freeze-dried, yielding a 3.78%
(w/w) crude extract. The crude extract was stored at 4°C
in an airtight container. The stock solution of CF extract
was freshly prepared and dissolved in 100% DMSO, and
the concentration of DMSO in all experiments was re-
stricted to ≤ 1% to maintain the cytotoxicity at < 10%.Cytotoxicity assay
Cell viability was measured by an NR colorimetric assay.
Human HepG2 cells and normal African green monkey
kidney Vero cells were used as cell models to determine
the percent cytotoxicity. Briefly, cells (4 × 106 cells/mL)
were treated with CF extract at various concentrations
(10, 25, 50, 100, 250, and 500 μg/mL) and the standard
anticancer drug melphalan as a positive control, while
the untreated groups were exposed to fresh medium at
equal volumes to those used for the treated groups. After
24 h of exposure, the cells were incubated for 2 h with
NR dye (50 μg/mL) dissolved in DMEM, and then
washed with phosphate-buffered saline (PBS; pH 7.4). Fi-
nally, the cells were lysed with 0.33% HCl/isopropanol. A
microplate reader (Tecan, France) was used to measure
the absorbances of NR dye in the viable cells at 520 and
650 (reference) nm. The percentage of cell cytotoxicity of
the CF extract was calculated as described by Machana
et al. [18] and compared with that of melphalan. The se-
lectivity index (SI) was calculated to determine theselective cancer cell line cytotoxicity [9]. The SI of the
test compound was compared with the IC50 for the Vero
cells divided by the IC50 for the HepG2 cells.Apoptosis induction assay
DAPI staining assay
Cells (1 × 106 cells/well) were treated with CF extract
and the melphalan for 24 h at 2 × IC50, and the morpho-
logical changes of the induced apoptotic cells were de-
termined by DAPI staining. The concentrations of CF
extract and melphalan used in the following apoptosis
experiments were 120 and 80 μg/mL, respectively. The
cells were fixed in pure methanol at 4°C for 10 min, and
then stained with DAPI (1 μg/mL) at room temperature
in the dark. The excess dye was removed and glycerin
was added to the cells with PBS at a 1:1 ratio and mixed
well. Next, the cells were fixed on a slide and the apop-
totic bodies observed at 40× objective magnification
under an inverted fluorescence microscope (Eclipse
TS100; Nikon, UK). The percentage of apoptotic cells
was calculated as described by Machana et al. [18]. The
average% apoptotic cells were calculated from three in-
dependent wells with 10 eye views in each well.DNA fragmentation assay
HepG2 cells (1 × 106 cells/well) were treated with
120 μg/mL of CF extract or 80 μg/mL of melphalan for
24 h, harvested, and washed three times with sterile
PBS. Each cell suspension was transferred to a micro-
centrifuge tube (1.5 mL) and centrifuged (DAIHAN sci-
entific, Korea) at 300 × g for 5 min, and the cell pellet
was collected. A FlexiGene DNA kit was used to extract
the DNA in accordance with the manufacturer’s instruc-
tions. Subsequently, 2 μg of DNA was analyzed by electro-
phoresis (Gibthai, Taiwan) in a 1.8% agarose gel containing
0.1% (v/v) ethidium bromide. The DNA fragments were
Figure 3 DNA fragmentation in HepG2 cells treated with 80 μg/
mL of melphalan or 120 μg/mL of CF extract for 24 h.
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(Syngene, MD, USA) and an image of the electrophoresis
gel was taken.
Caspase activity assay
HepG2 cells (4 × 106 cells/mL) were seeded in a 96-well
plate, incubated overnight, and then treated with CF ex-
tract at 0, 30, 60, 120, and 240 μg/mL for 24 h (caspase
3/7 activity test) or 12 h (caspase 8, 9 activity test). In
addition, HepG2 cells were treated with CF extract
(120 μg/mL) at 0, 3, 6, 12, and 24 h for caspase 3/7 ac-
tivity and 0, 3, 6, 9, and 12 h for caspase 8 and 9 activ-
ity). The enzyme activity of caspase 3/7, 8, and 9 was
determined by Caspase-Glo® 3/7, 8, and 9 Assay Kits in
accordance with the manufacturer’s instructions. The
caspase activities were expressed as relative lumines-
cence units (RLU) in direct proportion to the luminescent
light and were detected by a microplate luminometer
(SpectraMax Gemini X, Sandy, UT, USA). Blank determi-
nations were performed on a test plate containing only
sample and medium. All of the experiments were per-
formed in triplicate.
Detection of mitochondrial membrane potential (MMP)
Cells (1 × 106 cells/mL) were seeded into a 24-well plate,
incubated at 37°C for 24 h, and then treated with 0, 30,
60, or 120 μg/mL of CF extract for 12 or 24 h. Concen-
trated hydrogen peroxide (35%, v/v) was used as a posi-
tive control. Next, the cells were washed, harvested by
trypsinization, transferred to a microcentrifuge tube, and
stained with a lipophilic fluorogenic dye, DiOC6, at 40
nM for 30 min in the dark at 37°C. After the incubation,
the cells were immediately analyzed by flow cytometry
(BD FACSCanto II, San Jose, CA, USA) for incorpor-
ation of the fluorochrome.
Determination of phenolics in the CF extract
The total phenolic content was determined by the Folin-
Ciocalteu reagent as described by Kaisoon et al. [19].
Briefly, 300 μL of CF extract was mixed with 2.25 mL of
Folin-Ciocalteu reagent (10-fold dilution with distilled
water). After standing at room temperature for 5 min,
2.25 mL of saturated NaHCO3 (60 g/L) solution was
added to the mixture. After 90 min, the absorbance of
the reaction mixture was measured at 725 nm by a UV-
spectrophotometer (Shimadzu, Japan). The results were
expressed as milligrams of gallic acid equivalents per 1 g
of dried sample (mg GAE/g dry weight).
Statistical analysis
The data were represented by the mean ± standard devi-
ation (SD) (n = 3). The statistical significance of differ-
ences for multiple-group comparisons was evaluated by










Figure 4 Activation of caspase-3/7, -8 and -9 in the HepG2 treated with the CF extract. Relative luminescent units (RLU) of (A) caspase 3/7,
(B) 8 and (C) 9, respectively, after HepG2 cells exposed to CF extract at various concentrations for 12 (for caspase 8, 9) and 24 (for caspase 3) h.
(D), (E), and (F) represent the caspase 3/7, 8, 9 activity after being treated with CF extract (120 μg/mL) at various points. Values represent a mean
± SD, based on triplicates. *P < 0.05, **P < 0.001 significantly different from untreated cells.
Nonpunya et al. Chinese Medicine 2014, 9:12 Page 5 of 9
http://www.cmjournal.org/content/9/1/12difference using SPSS Windows version 11.5 (SPSS, USA).
Evaluation with a two-tailed Student’s t-test was also per-
formed for two-group comparisons. Values of P < 0.05
were considered statistically significant.
Results
CF extract induced human HCC cell death
The cytotoxicity (Table 1) and growth inhibition (Figure 1)
results of the crude CF extract compared to melphalan
showed cytotoxicity with a 50% inhibitory concentration
(IC50 ± SD) of 55.9 ± 10.6 μg/mL for HepG2 cells while no
effect on normal Vero cells at concentrations up to
500 μg/mL. Melphalan exhibited an IC50 of 37.7 ± 9.8 μg/
mL for HepG2 cells, but showed low selectivity (SI = 1.6).
The CF extract showed high selectivity (SI = 8.9) against
HepG2 cells with a minimum effect on normal Vero cells.
The CF extract possessed potential cytotoxic activity to-
ward the HCC cell line in vitro.
CF extract induced apoptosis
CF caused nuclear morphological changes in HepG2 cells
Images of nuclear DNA staining by DAPI in untreated
(control) and treated HepG2 cells were shown inFigure 2. Nuclei with condensed chromatin and apop-
totic bodies, characteristic of late-stage apoptosis [20],
were observed in HepG2 cells incubated with the CF ex-
tract and the melphalan. The results revealed that the
CF extract caused a higher percentage of apoptosis
(62.2 ± 4.5%) as compared to melphalan alone (41.6 ±
2.1%). Apoptotic bodies were not observed in the un-
treated HepG2 cells.
CF induced apoptotic DNA fragmentation in HepG2 cells
Apoptotic cell death leads to regulated nuclear frag-
mentation by endonuclease enzymes in a controlled
manner that involves DNA fragmentation [20]. During
the apoptotic process, the release of endonuclease en-
zymes associated with DNA fragmentation in apoptotic
cells results in DNA laddering, which can be observed
by agarose gel electrophoresis [21]. This phenomenon
specifically indicates that treated cancer cells have
undergone late-stage apoptosis [22]. Figure 3 shows
that treatment of HepG2 cells with 120 μg/mL of CF
extract led to DNA laddering after 24 h of exposure,




Figure 5 Mitochondrial membrane potential in HepG2 cells
exposed to CF extract at various concentrations for (A) 12 h
and (B) 24 h, respectively, analyzed by flow cytometry. *P < 0.05
significantly different from untreated cells.
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CF induces apoptosis in HepG2 cells via activation of
caspase activity
Apoptotic cell death occurs via major extrinsic and in-
trinsic pathways. Caspases 3/7, 8, and 9 are the major
apoptotic caspases. Activation of caspase 8 indicates the
extrinsic pathway, while activation of caspase 9 indicates
the intrinsic pathway. When cells undergo apoptosis
through either the extrinsic or intrinsic pathway, caspase
3 activity is activated at the final step prior to cell death
[5-7]. The apoptosis induced in HepG2 cells by the CF
extract through caspase activity was initially observed at
30 μg/mL after 6 h of incubation (Figure 4). The CF ex-
tract increased caspases activity with dose and timedependent manner. At 24 h the CF extract at all concen-
tration tested significantly increased caspase 3/7 from the
untreated cells (P < 0.001, one-way ANOVA). The cells
treated with 30, 60, 120, and 240 μg/mL significantly in-
creased caspase 8 activity (P = 0.018, P = 0.029, P < 0.001,
P < 0.001, respectively, one-way ANOVA). However, no
significant difference of caspase 9 activity was observed
(one-way ANOVA) between the group of cells treated
with 30 and 60 μg/mL and the untreated cells (P = 0.150
and P = 0.100). Whereas the group of cells treated with
120, and 240 μg/mL significantly increased caspase 9 ac-
tivity compared to the untreated cells (P < 0.001, one-way
ANOVA).
At 3 h the CF extract (120 μg/mL) did not significantly
increase caspase 3/7 (P = 0.885), caspase 8 (P = 1.000),
and caspase 9 activity (P = 1.000) when compared to the
control (one-way ANOVA). The CF extract (120 μg/mL)
significantly increased caspase 3/7 at 6, 12, and 24 h
(P < 0.001, one-way ANOVA). The CF extract at the same
concentration did not significantly increased caspase 8 at
6 and 9 h (P = 0.597, and P = 0.07) but significantly in-
crease caspase 8 activity at 12 h (P < 0.001, one-way
ANOVA). Moreover, the CF extract at the same concen-
tration did not significantly increased caspase 9 at 6 and
9 h (P = 0.568, and P = 0.079) but significantly increase
caspase 9 activity at 12 h (P < 0.001, one-way ANOVA).
CF induced apoptosis in HepG2 cells through the
mitochondrial pathway
MMP changes after cells were exposed to the CF extract
at various concentrations were observed. The alteration
of MMP in the cells treated with 30 μg/mL CF extract
compared to untreated cells was not significantly differ-
ent at 12 and 24 h (P = 0.994 and P = 0.150, respectively).
The MMP alteration in the cells treated with 60 and
120 μg/mL CF extract and 35% (v/v) H2O2 were signifi-
cantly different from the untreated at 12 and 24 h (P <
0.001, one-way ANOVA) (Figure 5).
Total phenolic content of the CF extract
The total phenolic content was estimated by a Folin-
Ciocalteu colorimetric method by gallic acid as the stand-
ard phenolic compound [19]. The calibration curve of
gallic acid showed a linear correlation for gallic acid con-
centrations between 25–200 μg/mL, with an r2 of 0.997.
The total phenolic content was 5.36 mg GAE/g dry
weight of CF extract.
Discussion
The current treatment of HCC includes 5-fluorouracil
[23], doxorubicin, mitomycin C [24-26], cisplatin [25],
and melphalan [27,28]. The 50% ethanol-water extract of
CF inhibited the proliferation rate of HCC cells with a
higher SI than melphalan. Based on published guidelines,
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must have an IC50 of less than 100 μg/mL [9]. Our la-
boratory previously found that CF induced apoptosis in
leukemia cancer U937 cells [8] and this study aims to in-
vestigate the anticancer activity of 50% ethanol-water ex-
tract of CF.
Apoptosis was observed in the action mechanism of
anti-cancer drugs [5-8]. The failure to trigger apoptosis
was related to drug resistance and tumorigenesis [4].
Apoptosis includes both intrinsic and extrinsic pathways
[29], and can be observed by investigating DNA conden-
sation, membrane blebbing, and apoptotic body forma-
tion by staining cells with DAPI or Hoechst 3332 dye
and detecting morphological changes under an inverted
fluorescence microscope [29-31]. DNA fragmentation
has also been investigated by 2D gel electrophoresis [30].
However, DNA fragmentation can also occur under
non-apoptotic conditions [22].
Both apoptosis pathways are related to caspase activity,
specifically caspase 3, 8, and 9 activity [29,32,33], that can
be used to classify the extrinsic and intrinsic pathways
[31]. The intrinsic or mitochondrial pathway is caused by
nuclear DNA damage, resulting in alterations in the
MMP, and release of cytochrome c into the cytosol. Ul-
timately, caspase 9 is also activated [31]. In the present
study, the DNA condensation (Figure 2), MMP changes
(Figure 5), and caspase 9 activation (Figure 4C and F)
were observed after exposure of HepG2 cells to the CF
extract.
The caspase 8 is the key caspase for the extrinsic path-
way of apoptosis [34]. This extrinsic pathway of apop-
tosis occurred extrinsically from interactions of a death
receptor with death ligands. In this study, the caspase 8
activity in HepG2 cell was increased after exposure to
CF extract (Figure 4B and E).
Activation of caspase 8 and 9 also activates the execu-
tioner caspase 3/7, which can cleave several intracellular
proteins and leads to cell disruption, including apoptotic
body formation, chromosome breakage, and DNA frag-
mentation [30]. In the present study, CF induced the late
stages of apoptosis characterized by an increase in cas-
pase 3/7 activity (Figure 4A and D), as evidenced by
apoptotic body formation (Figure 2) and DNA fragmen-
tation (Figure 3). The induction of apoptosis by CF was
clearly demonstrated by caspase activity in both the ex-
trinsic and intrinsic pathways. Further studies of the
crude CF extract effects on cancer cell lines are necessary
to isolate the phytoconstituents contributing to the anti-
cancer activity.
Previously, benzophenone glycosides that inhibited
leukemia L1210 viability [35] were identified in a 60%
ethanol extract from CF stems [10,36]. Xanthones, an-
thraquinones, and cochinchinone were identified in di-
chloromethane extracts of CF roots and bark [13,37],and quercetin, xanthones, and mangiferin were found in
CF leaves and stem [38]. The bioactive compounds pos-
sessing anticancer activity in CF were cochinchinone A
[39,40], macluraxanthon [41], norcowanin [42,43], and
brasilixanthone [44]. Other activities were also reported
for the dichloromethane extract, in which dulcisxanthone
B had a DPPH-scavenging effect and inhibited lipid per-
oxidation [45].
The total phenolic content in the 50% ethanol-water ex-
tract of CF was 5.36 mg GAE/g dry weight of material. A
previous report defined a high phenolic content as 20 mg
GAE/g dry weight [46], based on the Folin-Ciocalteu
method. Thus, the total content of the CF extract found
in the present study would be considered low.
Conclusions
CF extract induced a caspase-dependent apoptosis in
HepG2 cell.
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